Dr. Eric Grigsby

NAPA, Calif., July 19, 2023 (Newswire.com) - Neurovations, a leading medical research and innovation company, is proud to have collaborated on a groundbreaking study investigating the effects of the monoclonal antibody, donanemab, on patients with the early stages of Alzheimer's Disease.

Neurovations began enrolling patients in 2021 in advance of Eli Lilly's recent announcement of positive results from the TRAILBLAZER-ALZ 2 Phase 3 trial. This study demonstrated that donanemab significantly slowed cognitive and functional decline in individuals with early Alzheimer's Disease.

"We are thrilled to be part of this vital research. Alzheimer's Disease affects nearly 1 million people in my home state of California," said Dr. Eric Grigsby. "This is a significant step forward in the fight against Alzheimer's, and we are optimistic about the impact this treatment may have on the members of my community with this condition."

Neurovations was founded in Napa in 1992 by Dr. Eric Grigsby and is a national leader in clinical research for pain and neurologic diseases, treatment for chronic pain, molecular diagnostics testing, and education programs focused on pain and neuroscience. 

The TRAILBLAZER-ALZ 2 study, a randomized, double-blind, placebo-controlled trial, evaluated the safety and efficacy of donanemab, an investigational, amyloid-targeting therapy. Participants with early symptomatic Alzheimer's disease were enrolled in the study, and those with confirmed presence of AD neuropathology completed their course of treatment with donanemab.

Neurovations Research was selected as a study site in 2021 and worked with Eli Lilly to contribute to this groundbreaking research. Dr. Grigsby's expertise and passion for advancing treatments for neurodegenerative diseases and chronic pain have been instrumental in the success of this collaboration.

Key findings from the TRAILBLAZER-ALZ 2 study include:

●   Nearly half (47%) of participants on donanemab showed no clinical progression at one year, defined as no decline in Clinical Dementia Rating-Sum of Boxes (CDR-SB), compared to 29% of participants on placebo.

●   Donanemab treatment slowed clinical decline by 35% compared to placebo, leading to a 40% reduction in the decline of activities of daily living.

These results have significant implications for the treatment of early symptomatic Alzheimer's disease and have prompted Lilly to move forward with FDA approval and global regulatory submissions. Neurovations and Dr. Eric Grigsby's involvement in this study have further enhanced the research community's understanding of the potential benefits of donanemab in Alzheimer's disease management.

"Alzheimer's Disease affects an estimated 6.7 million Americans aged 65 and older. This first step is monumental on the path to a cure. We are thrilled to have been part of the study and sincerely hope to begin offering the treatment as soon as possible," stated Dr Grigsby.

EMERYVILLE, Calif., July 19, 2023 (Newswire.com) - Jovive Health, a provider of flexible, patient-centric primary and urgent care services owned and operated by Vituity, proudly announces that LegitScript has certified its in-person addiction treatment protocol. LegitScript is the industry leader in merchant and advertiser certification and monitoring in the e-commerce and payment sectors, and its industry-leading certification recognizes the highest levels of commercial integrity and compliance with applicable laws and regulations. LegitScript is the only certification program recognized by Google, Microsoft, and Facebook for the addiction treatment market. 

Jovive Health clinics in California, Nevada, and Illinois provide LegitScript-certified Medication-Assisted Treatment (MAT) for patients with Opioid Use Disorder (OUD) to help diminish the effects of physical dependence on opioids. According to the American Society of Addiction Medicine, individuals prescribed these FDA-approved medications as part of their OUD treatment are 75% less likely to die from an overdose than those who are not.

"This certification from LegitScript demonstrates that Jovive Health clinics have the highest level of credibility, expertise, and training in addiction treatment," said Taylor Nichols, MD, Clinical Lead for MAT at Jovive Health. "We are proud to be officially recognized for our commitment to providing evidence-based, appropriate medication-assisted treatment for opioid use disorder."

As the leading third-party certification expert in complex healthcare sectors, LegitScript has earned the trust of regulatory authorities and major advertising and e-commerce platforms worldwide. Certification involves a rigorous process of documentation, interviews, onsite inspections, and more to ensure that each facility provides the trained resources and tools to deliver care for opioid use disorder.

Jovive Health clinics offer convenient same-day access to comprehensive primary and urgent care services with extended hours and telehealth appointments. Patients 18 years and older can book online or walk in for a MAT consultation with a provider to confirm eligibility and begin treatment. New patients enroll in a multi-appointment MAT program that is designed to stabilize symptoms and develop an individualized treatment plan. Treatment is available at a reasonable out-of-pocket cost and is covered by most insurance plans.

About Vituity

For nearly 50 years, Vituity has been a catalyst for positive change in healthcare. As a 100% physician-led and -owned multispecialty partnership with a nationwide footprint, nearly 5,000 Vituity clinicians care for more than 8 million patients across 450 practice locations.

Partnering with hospitals, health systems, clinics, payers, employers, and state and local government, our footprint continues to rapidly expand. Learn more at vituity.com.

About Jovive Health

At Jovive Health, we believe better medicine is founded on being connected to our communities, each other, and, most importantly, our patients. Jovive Health delivers a flexible, integrated care experience that includes virtual visits, online reservations and walk-ins, and extended hours. Jovive is owned and operated by Vituity, a national physician partnership with a history of healthcare quality and innovation. For addresses, services, and hours, visit jovivehealth.com.

TEMPE, Ariz., July 19, 2023 (Newswire.com) - Panoramic Health, the nation's leading integrated, physician-led, value-based kidney care platform announces its strategic partnership with San Antonio Kidney Disease Center (SAKDC), a distinguished nephrology practice serving South Texas. This collaboration marks Panoramic Health's sixth partnership with leading nephrology practices in Texas within the last year. Panoramic Health is the premier clinically oriented, value-based care platform improving patient outcomes and slowing disease progression for patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). 

Panoramic Health continues its rapid expansion in Texas through SAKDC and other recent partnerships with prominent nephrology practices including Renal Associates, P.A. (RAPA) and The Kidney Institute (TKI), extending its reach to a diverse population approaching 100,000 patients in key metropolitan areas such as Houston, Dallas, and San Antonio. This strategic partnership with SAKDC integrates Panoramic Health's industry-leading predictive analytics, clinical workflows, and holistic care coordination across SAKDC's offices. 

As the country's largest physician-led CKCC program participant, Panoramic Health is increasing access to holistic care at reduced costs for more than 30,000 Medicare beneficiaries in 18 Kidney Contracting Entities (KCEs) managing more than $1.5 billion in risk spending.

"We deeply appreciate our existing partnership with SAKDC in Panoramic Health's CKCC program. Their swift recognition of Panoramic Health's value as a partner has allowed us to enter into a more comprehensive partnership beyond their original value-based care affiliation with us," stated Rocky Chanana, Senior VP of Business Development. "SAKDC will continue to maintain clinical autonomy while leveraging Panoramic Health's integrated, holistic, value-based care platform and support services, leading to improved patient outcomes while enabling the nephrologist to remain at the center of care delivery." 

Panoramic Health's state-of-the-art tools and technologies, including its largest, real-time CKD database, powers predictive analytics and data-driven care interventions for patients in South Texas.

"This new partnership will further support our group's mission to providing comprehensive and innovative patient-centered care to South Texas. We are committed to helping lead the nephrology community in collaboration with Panoramic Health as we transition to value-based care and population health management while further supporting kidney transplantation and innovative research for kidney disease," said Dr. Wesley Calhoun, President of SAKDC. 

About Panoramic Health 

Panoramic Health is the nation's leading integrated physician-led value-based kidney care organization and the largest physician-led CKCC participant. Panoramic Health remains committed to keeping nephrologists independent, relevant, and at the center of care delivery. Panoramic Health's value-based care delivery platform is driven by proprietary, predictive data analytics and clinical workflows underpinned by one of the world's largest clinical chronic kidney disease ("CKD") data warehouses that enable nephrologists to deliver better patient outcomes through value-based care and clinical research. Panoramic Health's Clinical Research division partners with sponsors and clinical research organizations to bring cutting-edge treatments to patients with kidney disease. For more information, visit panoramichealth.com. 

About San Antonio Kidney Disease Center

SAKDC was founded in 1978 and has 20 office locations serving patients with CKD and ESRD. With 30 dialysis centers and affiliations with 15 hospitals, SAKDC ensures comprehensive care for its patients. The board-certified physicians and nurse practitioners at SAKDC deliver compassionate, individualized care across a range of services including advanced hospital treatments, kidney transplant procedures, and outpatient dialysis. 

In addition, SAKDC offers free classes on kidney health, diet, and disease prevention, facilitated by full-time educators. Guided by an understanding of each patient's unique needs and lifestyle, the medical professionals at SAKDC develop personalized and customized treatment plans. For more information about San Antonio Kidney Disease Center, please visit the website at sakidney.com.

For press inquiries, please contact [email protected].